BRIEF published on 09/10/2024 at 18:30, 2 months 12 days ago Fuller, Smith & Turner PLC: Transaction in Own Shares London Stock Exchange Ordinary Shares Share Buyback Investment Fuller’s
PRESS RELEASE published on 09/10/2024 at 18:25, 2 months 12 days ago Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 10,241 'A' ordinary shares as part of its share buyback program Voting Rights London Stock Exchange Share Buyback Program Fuller, Smith & Turner PLC Numis Securities Limited
BRIEF published on 09/09/2024 at 19:10, 2 months 13 days ago Fuller, Smith & Turner PLC: Director / PDMR Shareholding PDMR Shareholding Fuller, Smith & Turner EU Market Abuse Regulation Family Trust Retail Director
BRIEF published on 09/09/2024 at 19:05, 2 months 13 days ago Fuller, Smith & Turner PLC: Director Transfers Shares to Trust Market Abuse Regulation Shareholding Fuller, Smith & Turner Family Trust Michael Turner
PRESS RELEASE published on 09/09/2024 at 19:05, 2 months 13 days ago Fuller, Smith & Turner PLC: Director / PDMR Shareholding Fuller, Smith & Turner PLC announces Director / PDMR Shareholding details per market regulations. Frederick Turner appointed trustee of family trust holding 88,976 'A' Ordinary Shares without beneficial interest PDMR Fuller Smith Turner PLC Shareholding Director Market Regulations
PRESS RELEASE published on 09/09/2024 at 19:00, 2 months 13 days ago Fuller, Smith & Turner PLC: Director / PDMR Shareholding Fuller, Smith & Turner PLC Chairman gifts shares to family trust. Michael Turner retains 182,402 'A' Ordinary Shares. Regulatory disclosure under EU Market Abuse Regulation Shares Fuller, Smith & Turner PLC Chairman EU Market Abuse Regulation Family Trust
BRIEF published on 09/09/2024 at 18:49, 2 months 13 days ago Fuller, Smith & Turner PLC Announces Share Buyback Transaction London Stock Exchange Share Buyback Treasury Shares Market Regulation Fuller’s
PRESS RELEASE published on 09/09/2024 at 18:44, 2 months 13 days ago Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of 20,000 'A' ordinary shares at 746.00 GBp each as part of share buyback program. Shares to be held in Treasury London Stock Exchange Share Buyback Program Numis Securities Limited Fuller Smith Turner PLC 'A' Ordinary Shares
BRIEF published on 09/06/2024 at 18:20, 2 months 16 days ago Fuller, Smith & Turner PLC: Transaction in Own Shares Share Buyback Market Abuse Regulation Treasury Shares FCA Disclosure Fuller’s
PRESS RELEASE published on 09/06/2024 at 18:15, 2 months 16 days ago Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 20,000 'A' ordinary shares at an average price of 735.0000 GBp each on 06/09/2024 for its share buyback programme London Stock Exchange Share Buyback Programme Numis Securities Limited Fuller Smith Turner PLC Share Purchase
Published on 11/22/2024 at 23:55, 4 hours 38 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 5 hours 3 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 5 hours 28 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 6 hours 3 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 10 hours 18 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 10 hours 39 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 11 hours 37 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 12 hours 32 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 1 day 21 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 9 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 10 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 10 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
